Wafa S. Aljuaid

Wafa S. Aljuaid

Auto-generated profile, based on publicly available information

Wafa S. Aljuaid

Department of Chemistry, Taif University, Taif 26571, Saudi Arabia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2026 in Modern Physics Letters B
Verified
Journal Article
Closed access
PDF file
ARAhmed AZZOUZ RACHED
Ahmed AZZOUZ RACHED
AUAmir Ullah
Amir Ullah
SASalma Alshehri
Salma Alshehri
VTVineet Tirth
Vineet Tirth
AAAli Algahtani
Ali Algahtani
MHMudasser Husain
Mudasser Husain

11 May 2026 in Modern Physics Letters B
Verified
Journal Article
Closed access
PDF file
AUAmir Ullah
Amir Ullah
VTVineet Tirth
Vineet Tirth
AAAli Algahtani
Ali Algahtani
WAWafa S. Aljuaid
Wafa S. Aljuaid
EAEman M. Alshehri
Eman M. Alshehri
NRNasir Rahman
Nasir Rahman

1 January 2022 in TURKISH JOURNAL OF CHEMISTRY
Verified
Journal Article
Open access
PDF file
LBLaila M. Break
Laila M. Break
AGAdil Gobouri
Adil Gobouri
WAWafa S. Al-Harthi
Wafa S. Al-Harthi
Mohamed E HagarMohamed E Hagar
Mohamed E Hagar
NANadia Al-KAFF
Nadia Al-KAFF
MSMusa Said
Musa Said
Synthesis of a new fluorinated nucleoside of 6,7-difluoro-2-methyl-4-quinazolinone was described. 2-Amino-4,5-difluorobenzoic acid 1 reacts with (CH3CO)2O followed by ammonia to form (1H)-6,7-difluoro-2-methyl-4-quinazolinone 3a. Ribosylation of a silylated 4 with l-O-acety1-2,3-5-tri-O-benzoyl-α-D-ribofuranose 5 forms a protected nucleoside 6 then unprotected from 6 to give a free nucleoside 7. Greener pasture biological docking of the cystine protease of COVID-19 [Mpro, code 7BQY, PDB] by novel nucleoside and fluoroquinazoline compounds is presented. LIGPLOT (2D) representations calculated for the same ligands are shown. A superposition of remdesivir approved medicine, N3 inhibitor, and our ligands docked together into the binding protein of 7BQY is also given for a fair comparison. The binding affinities of remdesivir, N3 inhibitor, the nucleoside 7, and fluoroquinazoline 3a, 3b compounds with 7BQY calculated under the same conditions are -7.7, -7.4, -7.6, -6.1, and -6.1 kcal mol-1, respectively. The high values were due to the existence of many hydrophobic interactions and hydrogen bonds between the ligands and the active amino acid residues of the receptor, indicating a promising candidate as a COVID-19 inhibitor. Pro Tox -II server showed that compound 7 has a similar feature to the approved antiviral drug remdesivir for COVID-19. Additionally, a fascinating molecular modeling investigation showed that our nucleoside demonstrated good binding inhibition of AChE enzyme towards advancing an efficient medication against Alzheimer's disease. Finally, DFT has been conducted to illustrate the MD results in terms of the molecular descriptor-based structural activity relationship calculated from FMOs.

12 February 2026 in Modern Physics Letters B
Verified
Journal Article
Closed access
SSSajjad Shafi
Sajjad Shafi
SASalma Alshehri
Salma Alshehri
WAWafa S. Aljuaid
Wafa S. Aljuaid
SQSaleha Qissi
Saleha Qissi
NRNasir Rahman
Nasir Rahman
HRHamza Rekab-Djabri
Hamza Rekab-Djabri

23 August 2023 in Journal of Magnetism and Magnetic Materials
Verified
Journal Article
Closed access
WAWafa S. Aljuaid
Wafa S. Aljuaid
XFXin Fan
Xin Fan